API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
Details:
Ilevro (nepafenac) is a non-steroidal anti-inflammatory drug (NSAID). It stops the body from making chemicals that cause inflammation, which helps lessen pain and swelling in the eye due to surgery.
Lead Product(s): Nepafenac
Therapeutic Area: Ophthalmology Product Name: Ilevro
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Novartis Pharmaceuticals Corporation
Deal Size: $130.0 million Upfront Cash: Undisclosed
Deal Type: Acquisition January 23, 2023
Details:
Ilevro® (nepafenac ophthalmic suspension) is a 0.3%, a non-steroidal, anti-inflammatory eye drop indicated for pain and inflammation associated with cataract surgery.
Lead Product(s): Nepafenac
Therapeutic Area: Ophthalmology Product Name: Ilevro
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Harrow
Deal Size: $175.0 million Upfront Cash: Undisclosed
Deal Type: Acquisition December 14, 2022